recent treatment
Recently Published Documents


TOTAL DOCUMENTS

183
(FIVE YEARS 49)

H-INDEX

15
(FIVE YEARS 4)

2021 ◽  
pp. 0734242X2110667
Author(s):  
Valentina Grossule ◽  
Ding Fang ◽  
Dongbei Yue ◽  
Maria Cristina Lavagnolo ◽  
Roberto Raga

When approaching the study of new processes for leachate treatment, each influencing variable should be kept under control to better comprehend the treatment process. However, leachate quality is difficult to control as it varies dramatically from one landfill to another, and in line with landfill ageing. To overcome this problem, the present study investigated the option of preparing a reliable artificial leachate in terms of quality consistency and representativeness in simulating the composition of real municipal solid waste (MSW) leachate, in view of further investigate the recent treatment process using black soldier fly (BSF) larvae. Two recipes were used to simulate a real leachate (RL): one including chemical ingredients alone (artificial synthetic leachate-SL), and the other including chemicals mixed with artificial food waste (FW) eluate (artificial mixed leachate-ML). Research data were analysed, elaborated and discussed to assess simulation performance according to a series of parameters, such as Analytical representativeness, Treatment representativeness (in this case specific for the BSF larvae process), Recipe relevance, Repeatability and Flexibility in selectively modifying individual quality parameters. The best leachate simulation performance was achieved by the synthetic leachate, with concentration values generally ranging between 97% and 118% of the RL values. When feeding larvae with both RL and SL, similar mortality values and growth performance were observed.


2021 ◽  
pp. 82-83
Author(s):  
Manju. J ◽  
Priya Ramani ◽  
Rabitha . B

Oral sub mucous brosis is a potentially premalignant disorder which has multiple etiological factors among which habit of using tobacco especially chewing betel quid and arecanut is the important risk factor .The aim of this article is to emphasize on the etiopathogenesis and various recent treatment modalities that are available


2021 ◽  
Vol 126 (3) ◽  
pp. 329-335
Author(s):  
Christian Bontems

About the validity of Oreina (Chrysochloa) cacaliae tristis (Coleoptera, Chrysomelidae). The status of Oreina cacaliae tristis (Fabricius, 1792), established for more than two centuries, is wholly confirmed by the fine elytral microsculpture and the blue colour of the insects, which represent moreover an isolated population of the occidental and central Alps. The recent treatment of tristis as a synonymous of Oreina cacaliae (Schrank, 1785) is not acceptable: tristis must be maintained as a subspecies of cacaliae.


Author(s):  
Esmaeil Mehraeen ◽  
Zeinab Najafi ◽  
Bagher Hayati ◽  
Mohammad Javaherian ◽  
Sajad Rahimi ◽  
...  

Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into a worldwide pandemic. Many clinical studies have been achieved to investigate treatments to confrontation of COVID-19. Therefore, we conducted a systematic reviewto describe the recent treatment strategies to treat COVID-19 patients. Methods: A systematic search was performed in the databases of PubMed, Scopus, Embase, Science direct, Up to date, and Web of Science using the keywords of Coronavirus, COVID-19, SARS-CoV-2, Novel Coronavirus, 2019-nCoV, Treatment, Medicine, Therapy, Intervention, Drug, Medications, and Cure. Results: We included 58 studies including 38 articles (eleven reviews, ten editorial documents, three case reports, one mix method, one cohort study,) and 19 published clinical trials. Review of studies showed that Lopinavir/Ritonavir (n=16), Remdesivir (n=13), Convalescent plasma (n=11), Chloroquine (n=11), Ribavirin (n=9), Hydroxychloroquine sulfate (n=8), Traditional Chinese Medicine (TCM) (n=8), and Arbidol (n=7), were the most frequently used therapies used to treat COVID-19 patients. Conclusion: In the absence of definitive treatment protocols, recently proposed approaches appear to be an effective therapy for accelerating the recovery of COVID-19 patients. Some of these treatments may have been in the early stages of testing. However, future preclinical and clinical trials are warranted to validate findings.


2021 ◽  
Vol 09 (05) ◽  
Author(s):  
Dr Rajendra Chaudhry (MD Medicine) ◽  

Author(s):  
Hai-Jun Hu ◽  
Xiu Liang ◽  
Hai-Lang Li ◽  
Huai-Yuan Wang ◽  
Jin-Fa Gu ◽  
...  

AbstractAlthough the recent treatment in melanoma through the use of anti-PD-1 immunotherapy is successful, the efficacy of this approach remains to be improved. Here, we explore the feasibility of combination strategy with the armed oncolytic adenovirus ZD55-IL-24 and PD-1 blockade. We find that combination therapy with localized ZD55-IL-24 and systemic PD-1 blockade leads to synergistic inhibition of both local and distant established tumors in B16-bearing immunocompetent mouse model. Our further mechanism investigation reveals that synergistic therapeutic effect is associated with marked promotion of tumor immune infiltration and recognition in both local and distant tumors as well as spleens. PD-1 blockade has no obvious effect on promotion of tumor immune infiltration and recognition. Localized therapy with ZD55-IL-24, however, can help PD-1 blockade to overcome the limitation of relatively low tumor immune infiltration and recognition. This study provides a rationale for investigation of such combination therapy in the clinic.


Medicina ◽  
2021 ◽  
Vol 57 (4) ◽  
pp. 336
Author(s):  
Guoda Varytė ◽  
Daiva Bartkevičienė

Radiation-induced vaginal stenosis (VS) is a common side effect of pelvic radiotherapy (RT). RT-induced VS may have various negative effects on women’s quality of life, in particular dyspareunia, decreased vaginal lubrication and difficulties in sexual intercourse. This narrative review provides the aspects of RT-induced VS pathogenesis, incidence, evaluation and associated risk factors. Available treatment modalities are discussed in the article, putting the focus on preliminary, although promising, experience in the use of hyaluronic acid and laser therapy in cancer survivors after pelvic RT.


Sign in / Sign up

Export Citation Format

Share Document